Skip Navigation Bar

Unified Medical Language System® (UMLS®)

2015AA UMLS Micromedex Source Information

Authority
RED BOOK® is produced by Micromedex®, a healthcare brand of Thomson Reuters.

Purpose
The purpose of RED BOOK is to allow comprehensive access to current and accurate drug pricing information.

Description
RED BOOK covers FDA-approved drug products. It includes prescription drugs, over-the-counter drugs, and nondrug products.

Metathesaurus Scope
The Metathesaurus representation of RED BOOK only contains information on branded clinical drugs and clinical drugs.

The Metathesaurus representation of RED BOOK contains information on approximately 28,064 branded clinical drugs and 26,697 clinical drugs.

Update Frequency
RED BOOK is updated daily.

Metathesaurus Update Frequency
RED BOOK is updated in each Metathesaurus release as part of RxNorm.

Sites Consulted

  1. Thomson Reuters Micromedex Clinical Evidence Solutions [Internet]. Thomson Reuters; c2011. RED BOOK Drug References; c2011 [cited 2011 Jul 8]. Available from: http://thomsonreuters.com/products_services/healthcare/healthcare_products/clinical_deci_support/micromedex_clinical_evidence_sols/med_safety_solutions/red_book/.